Skip to main content
. 2026 Jul 9;46:146. doi: 10.1007/s10571-026-01776-w

Table 2.

Overview of the functions of cysteine cathepsins in glial cells

Glial cell type Cysteine cathepsin Function References
Microglia Cathepsin B Indirectly induces microglia-dependent Aβ accumulation in neurons via β-secretase activity (Wu et al. 2017)
Promotes Aβ phagocytic clearance in Alzheimer’s disease (Cappellano et al. 2013; Comi and Tondo 2017; Nakanishi 2020b; Jiang et al. 2025)
Activates the NLRP3 inflammasome and triggers IL-1β release via caspase-1 (Halle et al. 2008; Terada et al. 2010; Hanamsagar et al. 2011; An et al. 2016; Xu et al. 2018a; Bai et al. 2018; Chevriaux et al. 2020)
Promotes neurotoxic polarization and neuroinflammation via NF-κB activation (Wendt et al. 2009; Ni et al. 2015, 2019; Inoue et al. 2022)
Impairs memory by degrading mitochondrial transcription factor A and producing reactive oxygen species and pro-inflammatory mediators (Ni et al. 2019)
Induces neuronal apoptosis via caspase-3 activation (Kingham and Pocock 2001)
Triggers apoptosis through Bid activation (Zhang et al. 2023c)
Cathepsin C Promotes neurotoxic polarization and neuroinflammation via protein kinase C/p38MAPK/NF-κB activation (Liu et al. 2019; Zhao et al. 2021)
Enhances neuroinflammation by inducing C-C motif chemokine ligand 2 and C-X-C motif chemokine ligand 2 (Zhao et al. 2021)
Cathepsin H Promotes neurotoxic polarization, neuroinflammation, and neuronal death (Fan et al. 2015)
Cathepsin K Promotes neurotoxic polarization and neuroinflammation (Wendt et al. 2009)
Cathepsin L Disrupts microvessel integrity via extracellular matrix degradation (Gu et al. 2015)
Promotes neurotoxic polarization and neuroinflammation via NF-κB activation (Xu et al. 2018b; Inoue et al. 2022; Zhang et al. 2025a)
Activates the NLRP3 inflammasome (Zhang et al. 2025a)
Mediates major histocompatibility complex II antigen presentation (Gresser et al. 2001)
Cathepsin S Promotes microglial activation and migration via extracellular matrix degradation (Hai et al. 2007; Lively and Schlichter 2013; Lowry and Klegeris 2018)
Promotes neurotoxic polarization and neuroinflammation via NF-κB activation (Wendt et al. 2009; Zhang et al. 2025b)
Processes the invariant chain to enable major histocompatibility complex II antigen presentation (Nakagawa et al. 1999; Riese and Chapman 2000; Gresser et al. 2001)
Cathepsin X Abolishes γ-enolase neuroprotection against Aβ and lipopolysaccharide via proteolytic cleavage (Obermajer et al. 2009; Hafner et al. 2013; Pišlar et al. 2017)
Promotes neurotoxic polarization, apoptosis, and neuroinflammation via PI3K/Akt activation (Wendt et al. 2009; Pišlar et al. 2017, 2020, 2022)
Astrocytes Cathepsin B Degrades Aβ and generates Aβ peptides (Oberstein et al. 2020)
Activates the NLRP3 inflammasome and triggers IL-1β release via caspase-1 (Qiao et al. 2016)
Cathepsin C Enhances neuroinflammation by inducing C-X-C motif chemokine ligand 2 (Zhao et al. 2021)
Cathepsin K Alters astrocyte number and phenotype (Dauth et al. 2011)
Cathepsin L Mediates major histocompatibility complex II antigen presentation (Gresser et al. 2001)
Cathepsin S Contributes to sensory impairment during neuroinflammation in EAE (Kim et al. 2020)
Oligodendrocytes Cathepsin X Impairs oligodendrocyte maturation and differentiation (Horvat et al. 2025)
*Cysteine cathepsins derived from microglia, astrocytes, and neurons affecting oligodendrocyte function. Cathepsin B* Impairs remyelination and promotes oligodendrocyte and neuronal damage (Ma et al. 2007)
Cathepsin C* Enhances demyelination in EAE (Durose et al. 2019)
Enhances demyelination by inducing C-X-C motif chemokine ligand 2 (Liang et al. 2016)

Produces toxic tumour necrosis factor-α and protective IL-1β and impairs myelin integrity

Enhanhes T-cell expansion and tertiary lymphoid structures, resulting in earlier onset and more severe chronic EAE

(Shimizu et al. 2017)

(Liu et al. 2025)

Cathepsin H* Contributes to EAE development (Okada et al. 2018)
Impairs remyelination and promotes oligodendrocyte and neuronal damage (Ma et al. 2007)
Cathepsin L* Contributes to EAE development (Allan and Yates 2015)
Impairs remyelination and promotes oligodendrocyte and neuronal damage (Ma et al. 2007)
Cathepsin X* Promotes IL-1β and neuroinflammation in EAE (Allan et al. 2017)
Cathepsin V* Enhances demyelination (Shimizu et al. 2017)

Aβ: amyloid beta, IL: interleukin, EAE: experimental autoimmune encephalomyelitis, NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells, NLRP3: NOD-leucine rich repeat and pyrin containing protein 3